Facebook Pixel

AUDIO: Dr. Jill Siegfried - Is Lung Cancer More Fatal In HRT Recipients?

By Expert
Rate This

She is on the cutting edge of lung cancer research that’s going on here in the United States, and she is a Professor and Chair of the Lung Cancer Research at University of Pittsburgh’s Department of Pharmacology and Chemical Biology. Dr. Siegfried, thank you so much for helping us empower women.

Dr. Jill Siegfried:
You are welcome. I am glad to participate.

We value and respect our HERWriters' experiences, but everyone is different. Many of our writers are speaking from personal experience, and what's worked for them may not work for you. Their articles are not a substitute for medical advice, although we hope you can gain knowledge from their insight.

Lung Cancer

Get Email Updates

Lung Cancer Guide

Have a question? We're here to help. Ask the Community.


Health Newsletter

Receive the latest and greatest in women's health and wellness from EmpowHER - for free!